Eric S. Winer

4.9k total citations
106 papers, 3.0k citations indexed

About

Eric S. Winer is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Eric S. Winer has authored 106 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hematology, 45 papers in Oncology and 35 papers in Genetics. Recurrent topics in Eric S. Winer's work include Acute Myeloid Leukemia Research (39 papers), Lymphoma Diagnosis and Treatment (23 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Eric S. Winer is often cited by papers focused on Acute Myeloid Leukemia Research (39 papers), Lymphoma Diagnosis and Treatment (23 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Eric S. Winer collaborates with scholars based in United States, Germany and United Kingdom. Eric S. Winer's co-authors include Jorge J. Castillo, Janice Gabrilove, Gerald A. Colvin, Charles S. Cleeland, Brenda Sarokhan, Robert B. Livingston, Lawrence H. Einhorn, Adam J. Olszewski, Peter J. Quesenberry and James N. Butera and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Eric S. Winer

100 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric S. Winer United States	27	1.2k	1.1k	810	666	585	106	3.0k
Antoine Martin France	24	748 0.6×	300 0.3×	872 1.1×	403 0.6×	515 0.9×	78	2.9k
Hirokazu Murakami Japan	26	475 0.4×	1.3k 1.2×	530 0.7×	885 1.3×	478 0.8×	204	2.6k
Deepa Bhojwani United States	31	957 0.8×	1.1k 1.0×	326 0.4×	731 1.1×	388 0.7×	111	3.5k
Siok‐Bian Ng Singapore	29	1.1k 0.9×	364 0.3×	1.2k 1.4×	1.7k 2.6×	221 0.4×	101	3.8k
June‐Won Cheong South Korea	29	625 0.5×	994 0.9×	417 0.5×	1.0k 1.6×	581 1.0×	182	2.7k
Meinolf Suttorp Germany	32	944 0.8×	2.6k 2.3×	287 0.4×	513 0.8×	1.2k 2.1×	184	4.0k
Satoshi Yamasaki Japan	32	582 0.5×	564 0.5×	332 0.4×	606 0.9×	196 0.3×	188	3.1k
Thierry Fest France	41	1.8k 1.5×	465 0.4×	1.6k 1.9×	1.4k 2.1×	862 1.5×	145	5.0k
John M. McCarty United States	23	983 0.8×	1.8k 1.6×	238 0.3×	590 0.9×	365 0.6×	70	3.6k
Gandhi Damaj France	28	514 0.4×	501 0.5×	841 1.0×	329 0.5×	698 1.2×	125	2.3k

Countries citing papers authored by Eric S. Winer

Since Specialization

Citations

This map shows the geographic impact of Eric S. Winer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Winer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Winer more than expected).

Fields of papers citing papers by Eric S. Winer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric S. Winer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Winer. The network helps show where Eric S. Winer may publish in the future.

Co-authorship network of co-authors of Eric S. Winer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric S. Winer. A scholar is included among the top collaborators of Eric S. Winer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric S. Winer. Eric S. Winer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winer, Eric S., Amit Verma, Katharina S. Götze, et al.. (2024). Preliminary safety, efficacy and molecular characterization of emavusertib (CA-4948) in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) with FLT3 mutation (FLT3m).. Journal of Clinical Oncology. 42(16_suppl). 6539–6539. 1 indexed citations

Metzeler, Klaus H., Uwe Platzbecker, Eric S. Winer, et al.. (2024). Predictive biomarkers of response to the IRAK4/FLT3 inhibitor emavusertib in hematological malignancies.. Journal of Clinical Oncology. 42(16_suppl). 6550–6550. 1 indexed citations

Vedula, Rahul S., Jeremy Koob, Jacqueline S. Garcia, et al.. (2024). CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias. Blood. 144(12). 1290–1299. 4 indexed citations

Abaza, Yasmin, Eric S. Winer, Guru Subramanian Guru Murthy, et al.. (2024). Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers. American Journal of Hematology. 99(4). 606–614. 12 indexed citations

Shimony, Shai, Yael Flamand, Yannis K. Valtis, et al.. (2024). Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen. Blood Cancer Journal. 14(1). 191–191. 2 indexed citations

Stahl, Maximilian, Yiwen Liu, Eric S. Winer, et al.. (2023). Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia. Leukemia Research. 132. 107351–107351. 2 indexed citations

Pelcovits, Ari, et al.. (2023). Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study. The Oncologist. 28(5). 462–e303. 2 indexed citations

Sadigh, Sam, Daniel J. DeAngelo, Jacqueline S. Garcia, et al.. (2023). Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. Modern Pathology. 37(1). 100352–100352. 2 indexed citations

Chen, Evan C., Geoffrey Fell, Olga Pozdnyakova, et al.. (2022). Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical Cancer Research. 29(5). 878–887. 6 indexed citations

10.

Yang, Jing, Ellen Weisberg, Xiaoxi Liu, et al.. (2021). Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2. Leukemia. 36(1). 210–220. 19 indexed citations

11.

Lane, Andrew A., Anthony S. Stein, Jacqueline S. Garcia, et al.. (2021). Safety and Efficacy of Combining Tagraxofusp (SL-401) with Azacitidine or Azacitidine and Venetoclax in a Phase 1b Study for CD123 Positive AML, MDS, or BPDCN. Blood. 138(Supplement 1). 2346–2346. 27 indexed citations

12.

Winer, Eric S.. (2020). Secondary Acute Myeloid Leukemia. Hematology/Oncology Clinics of North America. 34(2). 449–463. 19 indexed citations

13.

Winer, Eric S., Howard Safran, Bogusława Karaszewska, et al.. (2017). Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study. International Journal of Hematology. 106(6). 765–776. 36 indexed citations

14.

Widick, Page & Eric S. Winer. (2016). Leukocytosis and Leukemia. Primary Care Clinics in Office Practice. 43(4). 575–587. 7 indexed citations

15.

Seah, Davinia, et al.. (2014). Informational needs and the quality of life of patients in their first year after metastatic breast cancer diagnosis. The Journal of Community and Supportive Oncology. 12(10). 347–354. 18 indexed citations

16.

Chorzalska, Anna, Saad M. Khan, Diana O. Treaba, et al.. (2014). Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia. 28(11). 2165–2177. 11 indexed citations

17.

Winer, Eric S., et al.. (2012). PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies. Expert Opinion on Investigational Drugs. 21(3). 355–361. 32 indexed citations

18.

Colvin, Gerald A., David Berz, Muthalagu Ramanathan, et al.. (2009). Nonengraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism. Biology of Blood and Marrow Transplantation. 15(4). 421–431. 56 indexed citations

19.

Berz, David, Elise McCormack, Eric S. Winer, Gerald A. Colvin, & Peter J. Quesenberry. (2007). Cryopreservation of hematopoietic stem cells. American Journal of Hematology. 82(6). 463–472. 179 indexed citations

20.

Pettersson, Ånna, Eric S. Winer, Sarah Weksler‐Zangen, Åke Lernmark, & Howard J. Jacob. (1995). Predictability of heterozygosity scores and polymorphism information content values for rat genetic markers. Mammalian Genome. 6(8). 512–520. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact